However, incomplete vascularization [10, 11], disease reactivation [12], and other vascular abnormalities, such as branching, shunt vessels, and leaking peripheral vascular abnormalities, have been reported after treatment of ROP with intravitreal Anti-VEGF [13]. Here, VEGFA is linked to retinopathy of prematurity.